Beauty Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Beauty Press Releases.

Press releases published on September 8, 2026

Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Phillips Edison & Company to Present at BofA Securities 2026 Global Real Estate Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Big Brothers Big Sisters Calls on Canadians to Make Life Bigger for Young People

Indeterminate GlobeNewswire

Sep. 8, 2026

Grands Frères Grandes Sœurs invite les Canadiennes et Canadiens à ouvrir des horizons pour les jeunes

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

Sep. 8, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds

Indeterminate GlobeNewswire

Sep. 8, 2026

R1 Makes Fast Company’s Eighth Annual List of the Best Workplaces for Innovators in Biotech, Healthcare and Life Sciences

Indeterminate GlobeNewswire

Sep. 8, 2026

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

Sep. 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire

Sep. 8, 2026

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire

Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

Sep. 8, 2026

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire